Lindbrook Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.6M | Sell |
48,041
-14,103
| -23% | -$1.64M | 0.52% | 29 |
|
|
2024
Q4 | $5.26M | Sell |
62,144
-2,563
| -4% | -$217K | 0.47% | 33 |
|
|
2024
Q3 | $5.82M | Sell |
64,707
-5,619
| -8% | -$505K | 0.52% | 32 |
|
|
2024
Q2 | $5.66M | Sell |
70,326
-13,442
| -16% | -$1.08M | 0.53% | 31 |
|
|
2024
Q1 | $6.68M | Sell |
83,768
-318
| -0.4% | -$25.4K | 0.63% | 31 |
|
|
2023
Q4 | $6.69M | Sell |
84,086
-233
| -0.3% | -$18.5K | 0.67% | 25 |
|
|
2023
Q3 | $5.89M | Sell |
84,319
-150
| -0.2% | -$10.5K | 0.66% | 27 |
|
|
2023
Q2 | $6.07M | Buy |
84,469
+248
| +0.3% | +$17.8K | 0.65% | 25 |
|
|
2023
Q1 | $5.19M | Sell |
84,221
-329
| -0.4% | -$20.3K | 0.61% | 26 |
|
|
2022
Q4 | $6.52M | Buy |
84,550
+84,498
| +162,496% | +$6.52M | 0.8% | 18 |
|
|
2022
Q3 | $2K | Buy |
52
+43
| +478% | +$1.65K | ﹤0.01% | 1990 |
|
|
2022
Q2 | $0 | Sell |
9
-134
| -94% | – | ﹤0.01% | 2490 |
|
|
2022
Q1 | $6K | Sell |
143
-7
| -5% | -$294 | ﹤0.01% | 1496 |
|
|
2021
Q4 | $6K | Sell |
150
-250
| -63% | -$10K | ﹤0.01% | 1430 |
|
|
2021
Q3 | $13K | Sell |
400
-500
| -56% | -$16.3K | ﹤0.01% | 892 |
|
|
2021
Q2 | $61K | Hold |
900
| – | – | 0.01% | 408 |
|
|
2021
Q1 | $51K | Hold |
900
| – | – | 0.01% | 431 |
|
|
2020
Q4 | $73K | Buy |
900
+200
| +29% | +$16.2K | 0.02% | 303 |
|
|
2020
Q3 | $50K | Buy |
+700
| New | +$50K | 0.01% | 358 |
|
|
2020
Q2 | – | Sell |
-76
| Closed | -$4K | – | 1723 |
|
|
2020
Q1 | $4K | Sell |
76
-324
| -81% | -$17.1K | ﹤0.01% | 1061 |
|
|
2019
Q4 | $41K | Buy |
+400
| New | +$41K | 0.01% | 500 |
|
|
2019
Q3 | – | Sell |
-400
| Closed | -$10K | – | 1434 |
|
|
2019
Q2 | $10K | Buy |
+400
| New | +$10K | ﹤0.01% | 886 |
|